Company: PMVP
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001140361-25-015610
Chunk: 46

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 46
---
 first day of each fiscal year in an amount equal to the least of (i) 4,406,374 shares, (ii) five percent (5%) of the outstanding shares of common stock on the last day of the immediately preceding fiscal year or (iii) such other amount as our board of directors or any of its committees as will be administering the 2020 Plan may determine. On January 1, 2025, the number of shares of our common stock available for issuance under our 2020 Plan increased by 2,596,638 shares pursuant to these provisions. This increase is not reflected in the table above. |

| (3) | Our 2020 ESPP provides that the number of shares available for issuance under the 2020 ESPP will be increased on the first day of each fiscal year in an amount equal to the least of (i) 4,220,000 shares, (ii) one percent (1%) of the outstanding shares of common stock on the last day of the immediately preceding fiscal year or (iii) such other amount as may be determined by our board of directors or any of its committees as will be administering the 2020 ESPP may determine. In May 2024, we amended our 2020 ESPP to increase the maximum number of shares that each Eligible Employee (as defined in the 2020 ESPP) may be permitted to purchase in an Offering Period (as defined in the 2020 ESPP) to 25,000 shares. The number of shares available for issuance under our 2020 ESPP was not increased for the fiscal year ending December 31, 2025. |

28

TABLE OF CONTENTS

BENEFICIAL OWNERSHIP OF SHARES OF COMMON STOCK The following table sets forth certain information with respect to the beneficial ownership of our common stock as of April 8, 2025 for:

| • | each beneficial owner of 5% or more of the outstanding shares of our common stock; |

| • | each of our directors; |

| • | each of our named executive officers; and |

| • | all directors and executive officers as a group. |

The number of shares of common stock beneficially owned by each person or entity is determined in accordance with the applicable rules of the SEC and includes voting or investment power with respect to shares of our common stock. The information is not necessarily indicative of beneficial ownership for any other purpose. Unless otherwise indicated, to our knowledge, all persons named in the